Beijing Mefuvir Medicinal Science

Beijing Mefuvir Medicinal Science is a China-based biopharmaceutical company specializing in the research, development, and commercialization of innovative small molecule drugs and high-barrier formulations. The company maintains a strategic focus on anti-infective therapies, particularly for chronic Hepatitis B and influenza, as well as respiratory treatments for asthma and COPD. Mefuvir leverages its proprietary inhalation and sustained-release technology platforms to develop differentiated therapeutic options that address significant unmet medical needs. In addition to its internal drug pipeline, the company provides integrated R&D services and technical solutions to the broader pharmaceutical industry. Headquartered in Beijing, Mefuvir aims to provide high-quality, affordable medical solutions for both the domestic Chinese and international markets.